Confluent Medical Technologies, formed last year when Nitinol Devices & Components acquired Interface Catheter Solutions, last week said it closed another buyout for an unspecified amount. Get the full story at our sister site, Medical Design & Outsourcing.
Biomedical Structures LLC
DeVivo takes over the corner office at AngioDynamics | Personnel Moves
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.
Biomedical Structures names Dean Tulumaris President & CEO
WARWICK, RI, Sep 12, 2011 (MARKETWIRE via COMTEX) — Biomedical Structures, LLC (BMS), a provider of biomedical textiles for medical devices and other advanced clinical applications, today announced the appointment of Dean J. Tulumaris as president and chief executive officer.
"We are incredibly pleased to welcome Dean to BMS," said John Gray, founder of BMS and chief operating officer. "Dean has a proven record of strategic leadership success and deep medical device industry experience that will be very beneficial to the future of BMS as we continue to grow."
Biomedical Structures expands textile engineering footprint
Biomedical Structures LLC completed the addition of a clean-room for medical device textile production.
The Warwick, R.I.-based company said the new facility is purpose-built for manufacturing finer PET fibers, DSM Dyneema Purity, and other mono- and multi-filament polymer fibers for orthopedic, cardiovascular and general surgery applications.
Biomedical Structures drums up $3.75 million
Biomedical Structures LLC raised $3.75 million in an equity offering led by Ampersand Ventures, according to a securities filing and a press release.
The Warwick, R.I.-based company, which makes customized biomaterials and textiles for medical devices, "specializes in the design and manufacturing of crafted, non-woven fibers and biomaterials such as tissue scaffolds and woven vascular grafts," according to the press release.